The EBOVAC-Salone study is the first to asses the safety of a prime-boost vaccine regimen. Grameen Foundation is part of a consortium that includes the London School of Hygiene & Tropical Medicine and World Vision of Ireland.
Publication Date:
Friday, October 9, 2015External Link:
http://www.marketwatch.com/story/johnson-johnson-announces-start-of-clinical-trial-of-ebola-vaccine-regimen-in-sierra-leone-2015-10-09